Trial intelligence / Profile preview

REACH: Rectal Artesunate Bioavailability in Children with Severe Malaria

NCT02492178Phase 2Completed

Sponsor
University of Oxford
Start
Jul 2015
Primary completion
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of artesunate in malaria, sponsored by University of Oxford. Started Jul 2015; status: completed.

02

Drugs

artesunate
03

Conditions

malaria

Beyond the preview

Go deeper on NCT02492178.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02492178.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call